Quest Diagnostics Reports Q4 2024 Earnings with Revenue Growth and Guidance for 2025
Quest Diagnostics (DGX) reported Q4 2024 earnings with consolidated revenue of $2.62 billion, up 14.5%, driven by acquisitions and business expansion. The company also provided 2025 revenue guidance between $10.7 billion and $10.85 billion. Operating income and EPS saw significant increases, though weather had a negative impact on results.

Topics: Earnings EPS Guidance Operating Income Revenue Growth